Cargando…
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology
The bone scan continues to be recommended for both the staging and therapy response assessment of skeletal metastases from prostate cancer. However, it is widely recognised that bone scans have limited sensitivity for disease detection and is both insensitive and non-specific for determining treatme...
Autores principales: | Cook, Gary J. R., Azad, Gurdip, Padhani, Anwar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118401/ https://www.ncbi.nlm.nih.gov/pubmed/27933280 http://dx.doi.org/10.1007/s40336-016-0196-5 |
Ejemplares similares
-
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020) -
MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014) -
The Evolving Role of Nuclear Medicine and Molecular Imaging: Theranostics and Personalized Therapeutic Applications
por: Bozkurt, M. Fani, et al.
Publicado: (2018) -
Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018) -
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
por: Schoots, Ivo G., et al.
Publicado: (2019)